Ultragenyx Pharmaceutical Inc.

Overview

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company committed to developing novel therapies for rare genetic diseases. The company focuses on bringing transformative treatments to patients who have limited or no existing therapeutic options.

Therapeutic areas

API / Drug Master Files

Ultragenyx Pharmaceutical Inc. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TRIHEPTANOIN ULTRAPUREActive2013-03-01

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Ultragenyx Pharmaceutical Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.